Retinal Degeneration Fund

Perceive Pharma operates as a pharmaceutical company.

NVasc is an early-stage ophthalmology company with a focus on treating blindness.

Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits.

Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.

SparingVision is a biotechnology company developing genomic medicines for the treatment of blinding inherited retinal diseases.

Nacuity Pharmaceuticals is a pharmaceutical company that aims to develop a breakthrough treatment for retinitis pigmentosa.

SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.

Opus Genetics is a gene therapy company for ultra-rare blinding conditions.

Vedere Bio is developing gene therapy products to restore functional vision to patients who have suffered vision loss.

Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.